Clinical Scorecard: Lower Respiratory Tract Infections Linked to Rhinovirus in Hospitalized Adults: A Retrospective Analysis
At a Glance
Category
Detail
Condition
Human rhinovirus (HRV) infection causing lower respiratory tract infections (LRTIs) and pneumonia in adults
Key Mechanisms
HRV infects lower respiratory tract cells including alveolar epithelium, confirmed by immunofluorescence staining; HRV replication occurs at 37°C via ICAM-1 and CDHR3 receptors
Target Population
Hospitalized immunocompetent adults screened for HRV
Care Setting
Hospital inpatient setting with RT-PCR screening and bronchoalveolar lavage fluid (BALF) analysis
Key Highlights
HRV detected in 4.6% of hospitalized adults screened, with bimodal seasonal peaks (Feb–Apr, Sep–Nov).
Co-infections were common (49%), mainly bacterial (34.1%) and viral (25.7%), but HRV independently caused pneumonia in some cases.
Immunofluorescence staining confirmed HRV VP3 protein in lung biopsy specimens in 61.5% of tested cases, providing histological evidence of LRT infection.
Guideline-Based Recommendations
Diagnosis
Use RT-PCR testing of respiratory samples to detect HRV in hospitalized adults with respiratory symptoms.
Confirm pneumonia diagnosis by new lung infiltrates on imaging plus respiratory symptoms, excluding other pulmonary pathologies.
Exclude other respiratory pathogens via comprehensive microbiological testing (multiplex PCR, targeted PCR, bacterial and fungal cultures) to identify simple rhinovirus pneumonia.
Management
Recognize HRV as a potential independent cause of pneumonia, especially in males presenting with fever and cough.
Consider co-infections when managing HRV-positive patients due to high rates of bacterial and viral co-pathogens.
Monitoring & Follow-up
Monitor clinical symptoms such as fever and cough as predictors of HRV-associated pneumonia.
Observe seasonal trends to anticipate HRV infection peaks.
Risks
Male sex, presence of fever, and cough are independent predictors of simple rhinovirus pneumonia.
High co-infection rates may complicate clinical course.
Patient & Prescribing Data
Hospitalized adults with confirmed HRV infection
No specific antiviral treatment detailed; management should consider co-infections and clinical predictors such as fever and cough to guide supportive care.
Clinical Best Practices
Perform RT-PCR screening for HRV in hospitalized adults with respiratory symptoms to identify viral etiology.
Use lung biopsy with immunofluorescence staining when feasible to confirm HRV infection in lower respiratory tract cells.
Apply comprehensive microbiological testing to exclude other pathogens and accurately diagnose simple rhinovirus pneumonia.
Recognize clinical predictors (male sex, fever, cough) to identify patients at higher risk for HRV pneumonia.
Consider seasonal epidemiology in clinical suspicion and resource planning.
Amoxicillin-clavulanate was not linked to lower treatment failure but was associated with a slightly higher risk of secondary infections compared with amoxicillin in adults with uncomplicated acute sinusitis.
